This is a Validated Antibody Database (VAD) review about Saccharomy.. HHF2, based on 5 published articles (read how Labome selects the articles), using HHF2 antibody in all methods. It is aimed to help Labome visitors find the most suited HHF2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HHF2 synonym: histone H4

Abcam
rabbit polyclonal
  • ChIP-Seq; mouse; fig 1
  • western blot; mouse; fig s4
Abcam HHF2 antibody (Abcam, ab15823) was used in ChIP-Seq on mouse samples (fig 1) and in western blot on mouse samples (fig s4). Mol Cell (2015) ncbi
rabbit polyclonal
  • chromatin immunoprecipitation; human
Abcam HHF2 antibody (Abcam, ab15823) was used in chromatin immunoprecipitation on human samples . BMC Cancer (2013) ncbi
rabbit polyclonal
  • chromatin immunoprecipitation; mouse
  • western blot; mouse
Abcam HHF2 antibody (Abcam, ab46983) was used in chromatin immunoprecipitation on mouse samples and in western blot on mouse samples . J Neurosci (2013) ncbi
rabbit polyclonal
  • western blot; human
Abcam HHF2 antibody (Abcam, ab15823) was used in western blot on human samples . PLoS ONE (2012) ncbi
rabbit polyclonal
  • chromatin immunoprecipitation; Caenorhabditis elegans
  • chromatin immunoprecipitation; fruit fly
  • western blot; fruit fly; 1:1000 in dot blot a
Abcam HHF2 antibody (Abcam, ab15823) was used in chromatin immunoprecipitation on Caenorhabditis elegans samples , in chromatin immunoprecipitation on fruit fly samples and in western blot on fruit fly samples at 1:1000 in dot blot a. Nat Struct Mol Biol (2011) ncbi
Articles Reviewed
  1. Roe J, Mercan F, Rivera K, Pappin D, Vakoc C. BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. Mol Cell. 2015;58:1028-39 pubmed publisher
  2. Wagner M, Koslowski M, Paret C, Schmidt M, Tureci O, Sahin U. NCOA3 is a selective co-activator of estrogen receptor ?-mediated transactivation of PLAC1 in MCF-7 breast cancer cells. BMC Cancer. 2013;13:570 pubmed publisher
  3. Valor L, Guiretti D, Lopez Atalaya J, Barco A. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci. 2013;33:10471-82 pubmed publisher
  4. Coffey K, Blackburn T, Cook S, Golding B, Griffin R, Hardcastle I, et al. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PLoS ONE. 2012;7:e45539 pubmed publisher
  5. Egelhofer T, Minoda A, Klugman S, Lee K, Kolasinska Zwierz P, Alekseyenko A, et al. An assessment of histone-modification antibody quality. Nat Struct Mol Biol. 2011;18:91-3 pubmed publisher